Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Evaluation of a new DNA test for detection of carcinogenic human papillomavirus.

Castle PE, Gutierrez EC, Leitch SV, Maus CE, McMillian RA, Nussbaumer WA, Vaughan LM, Wheeler CM, Gravitt PE, Schiffman M.

J Clin Microbiol. 2011 Aug;49(8):3029-32. doi: 10.1128/JCM.00422-11. Epub 2011 Jun 1.

2.

Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests.

Gage JC, Sadorra M, Lamere BJ, Kail R, Aldrich C, Kinney W, Fetterman B, Lorey T, Schiffman M, Castle PE; PaP Cohort Study Group..

J Clin Microbiol. 2012 Jan;50(1):61-5. doi: 10.1128/JCM.05989-11. Epub 2011 Nov 9.

3.

Comparison of INNO-LiPA genotyping extra and hybrid capture 2 assays for detection of carcinogenic human papillomavirus genotypes.

Barzon L, Militello V, Pagni S, Palù G.

J Clin Virol. 2012 Nov;55(3):256-61. doi: 10.1016/j.jcv.2012.07.013. Epub 2012 Aug 9.

PMID:
22877561
4.

Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.

Park Y, Lee E, Choi J, Jeong S, Kim HS.

J Clin Microbiol. 2012 Jul;50(7):2359-65. doi: 10.1128/JCM.00337-12. Epub 2012 Apr 18.

5.

An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.

Thai H, Rangwala S, Gay T, Keating K, McLeod S, Nazarenko I, O'Neil D, Pfister D, Loeffert D.

J Clin Virol. 2009 Jul;45 Suppl 1:S93-7. doi: 10.1016/S1386-6532(09)70014-9.

PMID:
19651375
6.

Comparison of two PCR-based human papillomavirus genotyping methods.

Castle PE, Porras C, Quint WG, Rodriguez AC, Schiffman M, Gravitt PE, González P, Katki HA, Silva S, Freer E, Van Doorn LJ, Jiménez S, Herrero R, Hildesheim A; CVT Group..

J Clin Microbiol. 2008 Oct;46(10):3437-45. doi: 10.1128/JCM.00620-08. Epub 2008 Aug 20.

7.

Comparison of the GenoFlow human papillomavirus (HPV) test and the Linear Array assay for HPV screening in an Asian population.

Wong OG, Lo CK, Chow JN, Tsun OK, Szeto E, Liu SS, Ngan HY, Cheung AN.

J Clin Microbiol. 2012 May;50(5):1691-7. doi: 10.1128/JCM.05933-11. Epub 2012 Feb 15.

8.

Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection.

Kwon MJ, Roh KH, Park H, Woo HY.

J Clin Virol. 2014 Apr;59(4):246-9. doi: 10.1016/j.jcv.2014.01.015. Epub 2014 Jan 30.

PMID:
24568964
10.

Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping.

Castle PE, Sadorra M, Lau T, Aldrich C, Garcia FA, Kornegay J.

J Clin Microbiol. 2009 Oct;47(10):3344-7. doi: 10.1128/JCM.00725-09. Epub 2009 Aug 12.

11.

Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with the linear array HPV genotyping PCR assay and influence of DNA extraction method on HPV detection.

Roberts CC, Swoyer R, Bryan JT, Taddeo FJ.

J Clin Microbiol. 2011 May;49(5):1899-906. doi: 10.1128/JCM.00235-10. Epub 2011 Feb 23.

12.

Rapid genotyping of carcinogenic human papillomavirus by loop-mediated isothermal amplification using a new automated DNA test (Clinichip HPV™).

Satoh T, Matsumoto K, Fujii T, Sato O, Gemma N, Onuki M, Saito H, Aoki D, Hirai Y, Yoshikawa H.

J Virol Methods. 2013 Mar;188(1-2):83-93. doi: 10.1016/j.jviromet.2012.10.014. Epub 2012 Dec 5.

PMID:
23219807
13.

Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region.

Hesselink AT, Berkhof J, van der Salm ML, van Splunter AP, Geelen TH, van Kemenade FJ, Bleeker MG, Heideman DA.

J Clin Microbiol. 2014 Mar;52(3):890-6. doi: 10.1128/JCM.03195-13. Epub 2014 Jan 3.

14.

Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening.

Hesselink AT, Meijer CJ, Poljak M, Berkhof J, van Kemenade FJ, van der Salm ML, Bogaarts M, Snijders PJ, Heideman DA.

J Clin Microbiol. 2013 Jul;51(7):2409-10. doi: 10.1128/JCM.00633-13. Epub 2013 May 1.

15.

Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples.

Jentschke M, Soergel P, Hillemanns P.

J Virol Methods. 2013 Oct;193(1):131-4. doi: 10.1016/j.jviromet.2013.05.009. Epub 2013 May 23.

PMID:
23707925
16.

Comparative evaluation of AMPLICOR HPV PCR and Linear Array assays on SurePath liquid-based Pap samples for the detection of high-risk HPV genotypes.

Chernesky M, Jang D, Portillo E, Smieja M, Chong S, Buracond S, Klingel M, El Sebai R, Kapala J, Patel J, Biers K, Harroun N, Doucette C, Sumner J.

J Clin Virol. 2011 Mar;50(3):201-4. doi: 10.1016/j.jcv.2010.12.003. Epub 2010 Dec 30.

PMID:
21195020
17.

Human papillomavirus genotype specificity of hybrid capture 2.

Castle PE, Solomon D, Wheeler CM, Gravitt PE, Wacholder S, Schiffman M.

J Clin Microbiol. 2008 Aug;46(8):2595-604. doi: 10.1128/JCM.00824-08. Epub 2008 Jun 25.

18.

Detection and genotyping of human papillomavirus by real-time PCR assay.

Moreau F, Fetouchi R, Micalessi I, Brejeon V, Bacon N, Jannes G, Le Pendeven C, Lekbaby B, Kremsdorf D, Lacau Saint Guily J, Soussan P.

J Clin Virol. 2013 Mar;56(3):244-9. doi: 10.1016/j.jcv.2012.11.003. Epub 2012 Nov 22.

PMID:
23182775
19.

Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus.

Yu S, Kwon MJ, Lee EH, Park H, Woo HY.

J Med Virol. 2015 Sep;87(9):1587-93. doi: 10.1002/jmv.24206. Epub 2015 Apr 24.

PMID:
25914215
20.

Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.

Rao A, Sandri MT, Sideri M, Young S, Sharma A, Behrens C.

J Clin Virol. 2013 Sep;58(1):161-7. doi: 10.1016/j.jcv.2013.06.041. Epub 2013 Jul 27.

PMID:
23895930

Supplemental Content

Support Center